Financial Times
Sep 9, 2019 - 5 min
All in 1 subscription.
In an exclusive, Chris McGreal, writing in The Guardian, reveals that the head of the US Food and Drug Administration’s opioid advisory team says officials are manipulating process to benefit big pharma.